Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair.


Journal

Nature cardiovascular research
ISSN: 2731-0590
Titre abrégé: Nat Cardiovasc Res
Pays: England
ID NLM: 9918284280206676

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 28 06 2023
accepted: 07 12 2023
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: ppublish

Résumé

Tissue repair after myocardial infarction (MI) is guided by autocrine and paracrine-acting proteins. Deciphering these signals and their upstream triggers is essential when considering infarct healing as a therapeutic target. Here we perform a bioinformatic secretome analysis in mouse cardiac endothelial cells and identify cysteine-rich with EGF-like domains 2 (CRELD2), an endoplasmic reticulum stress-inducible protein with poorly characterized function. CRELD2 was abundantly expressed and secreted in the heart after MI in mice and patients. Creld2-deficient mice and wild-type mice treated with a CRELD2-neutralizing antibody showed impaired de novo microvessel formation in the infarct border zone and developed severe postinfarction heart failure. CRELD2 protein therapy, conversely, improved heart function after MI. Exposing human coronary artery endothelial cells to recombinant CRELD2 induced angiogenesis, associated with a distinct phosphoproteome signature. These findings identify CRELD2 as an angiogenic growth factor and unravel a link between endoplasmic reticulum stress and ischemic tissue repair.

Identifiants

pubmed: 39196188
doi: 10.1038/s44161-023-00411-x
pii: 10.1038/s44161-023-00411-x
doi:

Substances chimiques

Angiogenesis Inducing Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-202

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : WO 552/12-1
Organisme : Niedersächsisches Ministerium für Wissenschaft und Kultur (Ministry for Science and Culture of Lower Saxony)
ID : VW-ZN3440

Informations de copyright

© 2024. The Author(s).

Références

Anderson, J. L. & Morrow, D. A. Acute myocardial infarction. N. Engl. J. Med. 376, 2053–2064 (2017).
pubmed: 28538121 doi: 10.1056/NEJMra1606915
Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91–112 (2016).
pubmed: 27340270 pmcid: 4922528 doi: 10.1161/CIRCRESAHA.116.303577
Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M. & Bauersachs, J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur. Heart J. 43, 2549–2561 (2022).
pubmed: 35511857 pmcid: 9336586 doi: 10.1093/eurheartj/ehac223
Farbehi, N. et al. Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. eLife 8, e43882 (2019).
pubmed: 30912746 pmcid: 6459677 doi: 10.7554/eLife.43882
Korf-Klingebiel, M. et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat. Med. 21, 140–149 (2015).
pubmed: 25581518 doi: 10.1038/nm.3778
Reboll, M. R. et al. EMC10 (endoplasmic reticulum membrane protein complex subunit 10) is a bone marrow-derived angiogenic growth factor promoting tissue repair after myocardial infarction. Circulation 136, 1809–1823 (2017).
pubmed: 28931551 doi: 10.1161/CIRCULATIONAHA.117.029980
Reboll, M. R. et al. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase. Science 376, 1343–1347 (2022).
pubmed: 35709278 pmcid: 9838878 doi: 10.1126/science.abn3027
Gomez-Salinero, J. M., Itkin, T. & Rafii, S. Developmental angiocrine diversification of endothelial cells for organotypic regeneration. Dev. Cell 56, 3042–3051 (2021).
pubmed: 34813766 doi: 10.1016/j.devcel.2021.10.020
Wu, X., Reboll, M. R., Korf-Klingebiel, M. & Wollert, K. C. Angiogenesis after acute myocardial infarction. Cardiovasc. Res. 117, 1257–1273 (2021).
pubmed: 33063086 doi: 10.1093/cvr/cvaa287
Radanovic, T. & Ernst, R. The unfolded protein response as a guardian of the secretory pathway. Cells 10, 2965 (2021).
pubmed: 34831188 pmcid: 8616143 doi: 10.3390/cells10112965
Munro, S. & Pelham, H. R. A C-terminal signal prevents secretion of luminal ER proteins. Cell 48, 899–907 (1987).
pubmed: 3545499 doi: 10.1016/0092-8674(87)90086-9
Raykhel, I. et al. A molecular specificity code for the three mammalian KDEL receptors. J. Cell Biol. 179, 1193–1204 (2007).
pubmed: 18086916 pmcid: 2140024 doi: 10.1083/jcb.200705180
Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell Biol. 21, 421–438 (2020).
pubmed: 32457508 pmcid: 8867924 doi: 10.1038/s41580-020-0250-z
Bortnov, V. et al. Myeloid-derived growth factor is a resident endoplasmic reticulum protein. J. Biol. Chem. 293, 13166–13175 (2018).
pubmed: 29954947 pmcid: 6109940 doi: 10.1074/jbc.AC118.002052
Tadimalla, A. et al. Mesencephalic astrocyte-derived neurotrophic factor is an ischemia-inducible secreted endoplasmic reticulum stress response protein in the heart. Circ. Res. 103, 1249–1258 (2008).
pubmed: 18927462 pmcid: 2746824 doi: 10.1161/CIRCRESAHA.108.180679
Ghosh, R. et al. Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS ONE 5, e9575 (2010).
pubmed: 20221394 pmcid: 2833197 doi: 10.1371/journal.pone.0009575
Pereira, E. R., Liao, N., Neale, G. A. & Hendershot, L. M. Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response. PLoS ONE 5, e12521 (2010).
pubmed: 20824063 pmcid: 2932741 doi: 10.1371/journal.pone.0012521
Glembotski, C. C. Endoplasmic reticulum stress in the heart. Circ. Res. 101, 975–984 (2007).
pubmed: 17991891 doi: 10.1161/CIRCRESAHA.107.161273
Ren, J., Bi, Y., Sowers, J. R., Hetz, C. & Zhang, Y. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases. Nat. Rev. Cardiol. 18, 499–521 (2021).
pubmed: 33619348 doi: 10.1038/s41569-021-00511-w
Adamson, B. et al. A multiplexed single-cell CRISPR screening platform enables systematic dissection of the unfolded protein response. Cell 167, 1867–1882 (2016).
pubmed: 27984733 pmcid: 5315571 doi: 10.1016/j.cell.2016.11.048
Thuerauf, D. J. et al. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ. Res. 99, 275–282 (2006).
pubmed: 16794188 doi: 10.1161/01.RES.0000233317.70421.03
Oh-hashi, K. et al. CRELD2 is a novel endoplasmic reticulum stress-inducible gene. Biochem. Biophys. Res. Commun. 387, 504–510 (2009).
pubmed: 19615339 doi: 10.1016/j.bbrc.2009.07.047
Oh-hashi, K., Kunieda, R., Hirata, Y. & Kiuchi, K. Biosynthesis and secretion of mouse cysteine-rich with EGF-like domains 2. FEBS Lett. 585, 2481–2487 (2011).
pubmed: 21729698 doi: 10.1016/j.febslet.2011.06.029
Kim, Y. et al. Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease. JCI Insight 2, e92896 (2017).
pubmed: 29212948 pmcid: 5752286 doi: 10.1172/jci.insight.92896
Korf-Klingebiel, M. et al. Heparan sulfate-editing extracellular sulfatases enhance VEGF bioavailability for ischemic heart repair. Circ. Res. 125, 787–801 (2019).
pubmed: 31434553 doi: 10.1161/CIRCRESAHA.119.315023
Xu, D. & Esko, J. D. Demystifying heparan sulfate–protein interactions. Annu. Rev. Biochem. 83, 129–157 (2014).
pubmed: 24606135 pmcid: 7851832 doi: 10.1146/annurev-biochem-060713-035314
Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766–777 (2022).
pubmed: 35948637 pmcid: 9364862 doi: 10.1038/s41586-022-05060-x
Kern, P. et al. Creld2 function during unfolded protein response is essential for liver metabolism homeostasis. FASEB J. 35, e21939 (2021).
pubmed: 34549824 doi: 10.1096/fj.202002713RR
Hartley, C. L. et al. Armet/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: implications for genetic skeletal diseases. Hum. Mol. Genet. 22, 5262–5275 (2013).
pubmed: 23956175 pmcid: 3842181 doi: 10.1093/hmg/ddt383
Dennis, E. P. et al. CRELD2 is a novel LRP1 chaperone that regulates noncanonical WNT signaling in skeletal development. J. Bone Miner. Res. 35, 1452–1469 (2020).
pubmed: 32181934 doi: 10.1002/jbmr.4010
Willows, R. et al. Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells. Biochem. J. 474, 3059–3073 (2017).
pubmed: 28694351 doi: 10.1042/BCJ20170458
Alessi, D. R. et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541–6551 (1996).
pubmed: 8978681 pmcid: 452479 doi: 10.1002/j.1460-2075.1996.tb01045.x
Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167–1174 (2001).
pubmed: 11602624 pmcid: 209533 doi: 10.1172/JCI13505
Vlahos, C. J., Matter, W. F., Hui, K. Y. & Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241–5248 (1994).
pubmed: 8106507 doi: 10.1016/S0021-9258(17)37680-9
Tzahor, E. & Dimmeler, S. A coalition to heal—the impact of the cardiac microenvironment. Science 377, eabm4443 (2022).
pubmed: 36048959 doi: 10.1126/science.abm4443
Lynch, J. M. et al. A thrombospondin-dependent pathway for a protective ER stress response. Cell 149, 1257–1268 (2012).
pubmed: 22682248 pmcid: 3372931 doi: 10.1016/j.cell.2012.03.050
Bi, X. et al. Endoplasmic reticulum chaperone GRP78 protects heart from ischemia/reperfusion injury through Akt activation. Circ. Res. 122, 1545–1554 (2018).
pubmed: 29669712 pmcid: 5970094 doi: 10.1161/CIRCRESAHA.117.312641
Boyle, S. T. et al. ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism. Nat. Cell Biol. 22, 882–895 (2020).
pubmed: 32451439 doi: 10.1038/s41556-020-0523-y
Trychta, K. A., Back, S., Henderson, M. J. & Harvey, B. K. KDEL receptors are differentially regulated to maintain the ER proteome under calcium deficiency. Cell Rep. 25, 1829–1840 (2018).
pubmed: 30428351 pmcid: 7336508 doi: 10.1016/j.celrep.2018.10.055
Fisslthaler, B. & Fleming, I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ. Res. 105, 114–127 (2009).
pubmed: 19608989 doi: 10.1161/CIRCRESAHA.109.201590
Xu, M. J. et al. Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase alpha subunits. Arterioscler. Thromb. Vasc. Biol. 31, 1757–1765 (2011).
pubmed: 21597006 pmcid: 3158995 doi: 10.1161/ATVBAHA.111.227991
Shiojima, I. & Walsh, K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90, 1243–1250 (2002).
pubmed: 12089061 doi: 10.1161/01.RES.0000022200.71892.9F
Ackah, E. et al. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115, 2119–2127 (2005).
pubmed: 16075056 pmcid: 1180542 doi: 10.1172/JCI24726
Fu, H. Y. et al. Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation 122, 361–369 (2010).
pubmed: 20625112 doi: 10.1161/CIRCULATIONAHA.109.917914
Yao, Y. et al. A non-canonical pathway regulates ER stress signaling and blocks ER stress-induced apoptosis and heart failure. Nat. Commun. 8, 133 (2017).
pubmed: 28743963 pmcid: 5527107 doi: 10.1038/s41467-017-00171-w
Binet, F. & Sapieha, P. ER stress and angiogenesis. Cell Metab. 22, 560–575 (2015).
pubmed: 26278049 doi: 10.1016/j.cmet.2015.07.010
Chen, X. & Cubillos-Ruiz, J. R. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat. Rev. Cancer 21, 71–88 (2021).
pubmed: 33214692 doi: 10.1038/s41568-020-00312-2
Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell. Proteomics. 11, M111.014647 (2012).
pubmed: 22159717 doi: 10.1074/mcp.M111.014647
Korf-Klingebiel, M. et al. Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco/endoplasmic reticulum Ca
pubmed: 34372689 doi: 10.1161/CIRCULATIONAHA.120.053365
Prassler, J. et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J. Mol. Biol. 413, 261–278 (2011).
pubmed: 21856311 doi: 10.1016/j.jmb.2011.08.012
Yoshida, H. et al. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell. Biol. 20, 6755–6767 (2000).
pubmed: 10958673 pmcid: 86199 doi: 10.1128/MCB.20.18.6755-6767.2000
Nel, A. J., Garnett, S., Blackburn, J. M. & Soares, N. C. Comparative reevaluation of FASP and enhanced FASP methods by LC–MS/MS. J. Proteome Res. 14, 1637–1642 (2015).
pubmed: 25619111 doi: 10.1021/pr501266c
Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301–2319 (2016).
pubmed: 27809316 doi: 10.1038/nprot.2016.136
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).
pubmed: 27348712 doi: 10.1038/nmeth.3901
Motoike, T. et al. Universal GFP reporter for the study of vascular development. Genesis 28, 75–81 (2000).
pubmed: 11064424 doi: 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S
Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037–3047 (2007).
pubmed: 18025128 pmcid: 2118517 doi: 10.1084/jem.20070885
Wang, Y. et al. C-X-C motif chemokine receptor 4 blockade promotes tissue repair after myocardial infarction by enhancing regulatory T cell mobilization and immune-regulatory function. Circulation 139, 1798–1812 (2019).
pubmed: 30696265 pmcid: 6467561 doi: 10.1161/CIRCULATIONAHA.118.036053
Giannitsis, E. et al. Gender-specific reference values for high-sensitivity cardiac troponin T and I in well-phenotyped healthy individuals and validity of high-sensitivity assay designation. Clin. Biochem. 78, 18–24 (2020).
pubmed: 31786204 doi: 10.1016/j.clinbiochem.2019.11.013

Auteurs

Xuekun Wu (X)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Stanford University School of Medicine, Stanford, CA, USA.

Linqun Zheng (L)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Department of Cardiology, Shanghai General Hospital, Shanghai, China.

Marc R Reboll (MR)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Lillian F Hyde (LF)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Elvira Mass (E)

Developmental Biology of the Immune System, Life & Medical Sciences Institute, University of Bonn, Bonn, Germany.

Hans W Niessen (HW)

Department of Pathology and Department of Cardiac Surgery, Institute for Cardiovascular Research, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Maike Kosanke (M)

Research Core Unit Genomics, Hannover Medical School, Hannover, Germany.

Andreas Pich (A)

Core Unit Proteomics and Institute of Toxicology, Hannover Medical School, Hannover, Germany.

Evangelos Giannitsis (E)

Department of Medicine III, Heidelberg University, Heidelberg, Germany.

Jochen Tillmanns (J)

Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Johann Bauersachs (J)

Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Joerg Heineke (J)

Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Department of Cardiovascular Physiology, European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Yong Wang (Y)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Mortimer Korf-Klingebiel (M)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Felix Polten (F)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Kai C Wollert (KC)

Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany. wollert.kai@mh-hannover.de.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. wollert.kai@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH